Evidence map›Paper›PMID 22617420›Full record

ReviewThe EMBO journal2012

Three decades of Wnts: a personal perspective on how a scientific field developed.

Roel Nusse, Harold Varmus

Abstract readHistorical ArticleReview
In one paragraph

Review in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 227 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
227citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

227 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Wnt/CaOncology letters · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. The Noncanonical Wnt5a-CaJournal of cellular and molecular medicine · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Review

167 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roel NusseDepartment of Developmental Biology, Howard Hughes Medical Institute, Stanford University, School of Medicine, CA 94305-5458, USA. rnusse@stanford.edu
Harold Varmus

Funding

Cancer Biology and GeneticsZIAHG200375 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI VARMUS, HAROLD · 2011 to 2015
$6.6M
6 · The paper itself

Abstract

Wnt genes and components of Wnt signalling pathways have been implicated in a wide spectrum of important biological phenomena, ranging from early organismal development to cell behaviours to several diseases, especially cancers. Emergence of the field of Wnt signalling can be largely traced back to the discovery of the first mammalian Wnt gene in 1982. In this essay, we mark the thirtieth anniversary of that discovery by describing some of the critical scientific developments that led to the flowering of this field of research.

Indexed as

Gene Expression RegulationWnt Signaling PathwayAnimalsBiomedical ResearchHistory, 20th CenturyHistory, 21st CenturyHumansModels, Biological

Identifiers

PMID22617420
PMCPMC3380217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.